Schmid, P, Zaiss, M, Harper-Wynne, C, Ferreira, M, Dubey, S, Chan, S, Makris, A, Nemsadze, G, Brunt, AM, Kuemmel, S, Cabrero, IR, Perello, A, Kendall, A, Brown, J, Kristeleit, H, Conibear, J, Saura, C, Grenier, J, Mahr, K, Schenker, M, Sohn, JH, Lee, KS, Sarker, S-J, Coetzee, C, Mousa, K and Castan, JC (2018) MANTA - A randomized phase II study of fulvestrant in combination with the dual mTOR inhibitor AZD2014 or everolimus or fulvestrant alone in estrogen receptor-positive advanced or metastatic breast cancer. In: 2017 San Antonio Breast Cancer Symposium, December 5-9 2017, San Antonio, Texas.

Full text not available from this repository.
Item Type: Conference or Workshop Item (Paper)
Additional Information: The final version of this proceeding is available from the publisher at
Subjects: R Medicine > R Medicine (General)
Divisions: Faculty of Medicine and Health Sciences > Institute for Science and Technology in Medicine
Related URLs:
Depositing User: Symplectic
Date Deposited: 25 Nov 2019 15:16
Last Modified: 25 Nov 2019 15:16

Actions (login required)

View Item
View Item